FI68821C - Analogifoerfarande foer framstaellning av nya tetralinderivat vilka saenker blodtryck och oekar blodetsgenomstroemning - Google Patents

Analogifoerfarande foer framstaellning av nya tetralinderivat vilka saenker blodtryck och oekar blodetsgenomstroemning Download PDF

Info

Publication number
FI68821C
FI68821C FI782202A FI782202A FI68821C FI 68821 C FI68821 C FI 68821C FI 782202 A FI782202 A FI 782202A FI 782202 A FI782202 A FI 782202A FI 68821 C FI68821 C FI 68821C
Authority
FI
Finland
Prior art keywords
formula
compounds
och
carbon atoms
hydrogen
Prior art date
Application number
FI782202A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI782202A (fi
FI68821B (fi
Inventor
Max-Peter Seiler
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI782202A publication Critical patent/FI782202A/fi
Application granted granted Critical
Publication of FI68821B publication Critical patent/FI68821B/fi
Publication of FI68821C publication Critical patent/FI68821C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88Nitrogen atoms, e.g. allantoin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/42Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/66Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
FI782202A 1977-07-18 1978-07-10 Analogifoerfarande foer framstaellning av nya tetralinderivat vilka saenker blodtryck och oekar blodetsgenomstroemning FI68821C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH886377 1977-07-18
CH886377 1977-07-18
CH1358377 1977-11-08
CH1358377 1977-11-08

Publications (3)

Publication Number Publication Date
FI782202A FI782202A (fi) 1979-01-19
FI68821B FI68821B (fi) 1985-07-31
FI68821C true FI68821C (fi) 1985-11-11

Family

ID=25703869

Family Applications (1)

Application Number Title Priority Date Filing Date
FI782202A FI68821C (fi) 1977-07-18 1978-07-10 Analogifoerfarande foer framstaellning av nya tetralinderivat vilka saenker blodtryck och oekar blodetsgenomstroemning

Country Status (17)

Country Link
US (1) US4308266A (de)
EP (1) EP0000395B1 (de)
JP (1) JPS5422383A (de)
AU (1) AU521642B2 (de)
CA (1) CA1131641A (de)
CY (1) CY1224A (de)
DE (1) DE2860410D1 (de)
DK (1) DK309678A (de)
ES (2) ES471809A1 (de)
FI (1) FI68821C (de)
HK (1) HK85184A (de)
IE (1) IE47129B1 (de)
IL (1) IL55153A (de)
IT (1) IT1105089B (de)
NZ (1) NZ187876A (de)
PH (1) PH17238A (de)
PT (1) PT68306A (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4590274A (en) * 1985-01-03 1986-05-20 E. I. Du Pont De Nemours And Company Antihypertensive 1-[bis-(substituted phenyl)methyl]-4[2-(1,2,3,4-tetrahydro-substituted naphthalen-1-ylidene)ethyl]piperazines
GB8615560D0 (en) * 1986-06-25 1986-07-30 Maggioni Farma Aminoalcohols
WO1987002035A1 (en) * 1985-10-04 1987-04-09 Maggioni-Winthrop S.P.A. Fused cycloaliphatic aminoalcohols
IL85700A0 (en) * 1987-03-24 1988-08-31 Takeda Chemical Industries Ltd 1,4-disubstituted piperazine compounds,their production and use
US4845221A (en) * 1988-04-15 1989-07-04 American Home Products Corporation Serotonergic substituted piperazinyl tetralins
CA1335591C (en) * 1988-05-23 1995-05-16 James Arthur Nixon Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes
US4988699A (en) * 1989-03-14 1991-01-29 Warner-Lambert Company Substituted tetrahydrobenzothiazoles as dopaminergic agents
GB8907865D0 (en) * 1989-04-07 1989-05-24 Wyeth John & Brother Ltd Tetrahydroquinoline derivatives
US5194439A (en) * 1990-04-06 1993-03-16 John Wyeth & Brother Limited N-(2,3-dihydro-1,4-benzodioxinyl)-N-substituted aminopyrido-fused cycloalkanes
GB2290790A (en) * 1994-06-30 1996-01-10 Merck & Co Inc Asymmetric synthesis of 6-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1190466B (de) * 1961-11-07 1965-04-08 Cassella Farbwerke Mainkur Ag Verfahren zur Herstellung von Piperazinderivaten
CA969955A (en) * 1970-07-20 1975-06-24 Rene Viterbo Dihydronaphthalene derivatives
US4018773A (en) * 1975-09-15 1977-04-19 E. R. Squibb & Sons, Inc. Phenylpiperazinotetrahydronaphthols and derivatives

Also Published As

Publication number Publication date
IT1105089B (it) 1985-10-28
JPS5422383A (en) 1979-02-20
IL55153A (en) 1983-07-31
ES471809A1 (es) 1979-10-01
HK85184A (en) 1984-11-16
DK309678A (da) 1979-01-19
AU3808678A (en) 1980-01-17
NZ187876A (en) 1981-02-11
AU521642B2 (en) 1982-04-22
CY1224A (en) 1984-04-06
PT68306A (fr) 1978-08-01
FI782202A (fi) 1979-01-19
ES479059A1 (es) 1979-07-01
IE47129B1 (en) 1983-12-28
IT7850272A0 (it) 1978-07-13
PH17238A (en) 1984-07-03
IL55153A0 (en) 1978-09-29
EP0000395B1 (de) 1981-01-07
CA1131641A (en) 1982-09-14
DE2860410D1 (en) 1981-02-26
US4308266A (en) 1981-12-29
IE781438L (en) 1979-01-18
FI68821B (fi) 1985-07-31
EP0000395A1 (de) 1979-01-24

Similar Documents

Publication Publication Date Title
JP2020510642A (ja) o−アミノヘテロアリールアルキニル基含有化合物およびその製造方法と用途
SK10802002A3 (sk) 1,3-Disubstituované pyrolidíny, spôsob ich prípravy, ich použitie a farmaceutický prostriedok, ktorý ich obsahuje
JPH0314563A (ja) 新規4―フルオロ安息香酸誘導体
FI68821C (fi) Analogifoerfarande foer framstaellning av nya tetralinderivat vilka saenker blodtryck och oekar blodetsgenomstroemning
SK287018B6 (sk) Deriváty fenylpiperazínov, spôsob ich prípravy, farmaceutická kompozícia s ich obsahom a ich použitie
PT98768B (pt) Processo de preparacao de derivados de piperazinilo e de composicoes farmaceuticas que os contem
US6355642B1 (en) Tetrahydrobenzindole compounds
US4636563A (en) Antipsychotic γ-carbolines
HU227422B1 (en) Piperazine and piperidine derivatives, process for producing them and pharmaceutical compositions containing the same
US4748240A (en) Psychotropic bicyclic imides
JP6666458B2 (ja) 置換のアミノ6員窒素含有複素環式化合物およびその製造と使用
IE893265L (en) Quinolinone derivatives, their preparation and their¹application in therapy
US6028073A (en) N-substituted 3-azabicyclo (3.2.0)heptane derivatives useful as neuroleptics
KR100924405B1 (ko) 뉴로키닌 수용체 길항제로서의 신규한n-트리아졸일메틸-피페라진 유도체
EP1322621A1 (de) Benzimidazolonderivate mit affinität zu serotonin- und dopaminrezeptoren
IL90309A (en) History of 6-Phenyl-3-) Piperazinylacil (- H, 3H (- PHRHNHSHBSHUI, VFB1) -2,4 T I, U T FAHRH RUEJU T VNFHKHO TU T I
US6660751B1 (en) Sulfonamide derivatives as 5-HT7 receptor antagonists
RU2165420C2 (ru) 1,2,5-тиадиазольные производные индолилалкил-пиримидинил-пиперазинов и фармацевтическая композиция на их основе
CS248020B2 (en) Production method of the (+)-enantiomere or (+-)-racemical 4a,9b-trans-hexahydro-1h-pyridoindole derivatives
KR20010006587A (ko) 시아노-인돌 세로토닌 재흡수 억제 화합물, 이의 제조방법 및 이를 함유하는 약제학적 조성물
KR20000029564A (ko) 5HT2c길항제및D2길항제를함유하는약제학적조성물
NZ201642A (en) 1-phenylindazol-3-one derivatives and pharmaceutical compositions
CA1094553A (en) 1-amino substituted indoline derivatives as vasoconstricting agents
JPH037229A (ja) 脳神経機能改善剤
KR100917041B1 (ko) 5-ht7 수용체에 길항작용을 갖는 신규한 화합물

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: SANDOZ AG